Author NOWAK THORSTEN,THOMAS ANDREW P
Author_xml – fullname: NOWAK THORSTEN,THOMAS ANDREW P
BookMark eNqFyr0KwjAUhuEMOvh3DZ5RhwzaDjpKUZx0cS-H9AseaE9KEgv16nVwd3rh4Z2biQbFzNxLu-nHyO_Q2sKOLXeiYUtfkk4aUVCDKANnGZDIh0ivBBKl_ATlCM4dNFPw5Fgd4tJMPbcJq18XZn05P6qrRR9qpJ4dFLmubrvDsdyXxan4f3wASY83OA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID CN1894243A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN1894243A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:16:24 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN1894243A3
Notes Application Number: CN2004837801
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070110&DB=EPODOC&CC=CN&NR=1894243A
ParticipantIDs epo_espacenet_CN1894243A
PublicationCentury 2000
PublicationDate 20070110
PublicationDateYYYYMMDD 2007-01-10
PublicationDate_xml – month: 01
  year: 2007
  text: 20070110
  day: 10
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies ASTRAZENECA AB
RelatedCompanies_xml – name: ASTRAZENECA AB
Score 2.6629303
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070110&DB=EPODOC&locale=&CC=CN&NR=1894243A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dS8MwED_mFPVNpzK_8yBFH4Jrk67bwxCXbgxh3ZApextt2mJB27J2yvzrvdR1-rK3cIGQr1_ud8ndBeDGNCwjZMyk3NUl5brv0RbjLvWlbvmsKduWqwzFodMcvPCnqTmtwFsZC1PkCf0qkiMioiTiPS_O6_TvEssufCuzey9CUfLQn3RsrbSOLaXONLvb6Y1H9khoQnSEoznPCPI2Nzh73IJtJNGWwkLvtatiUtL_CqV_ADtjbCvOD6ESxDXYE-W_azXYHa6eu7G4Ql52BCNOb9Pl3P1O3imjS1zHKE7uCIqijwj1T0B83EufRRrvjCATJYssIFFMkOCRtTc5SUIi1TrPj-G635uIAcWezdaTMBNOOQR2AtU4iYM6EKQjTU82XBkij_BdvS0N09X1sKXiTxuWdwr1Ta2cba46h_3fG0zl7HYB1Xy-CC5R9ebeVTFrP8FbiPQ
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT8IwEL8gGvFNUYOf9MEs-tDIvhg8ECMdBBUGMWh4I123xSW6ETY0-Nd7nQx94a25Jk2_fr3ftXdXgCtTs7RA101qcFVQQ_Vc2tANTj2hWp5eF02LS0Nx4NR7L8bjxJwU4C2PhcnyhH5lyRERUQLxnmbn9ezvEsvOfCuTWzdEUXzXHbdsJbeOLanOFLvd6oyG9pApjLWYozjPCPKmoRn6_RZsI8G2JBY6r20ZkzL7r1C6-7Azwrai9AAKflSGEsv_XSvD7mD13I3FFfKSQxga9Hq2nPPv-J3qdInrGEbxDUFR-BGi_vGJh3vpM0vjnRBkomSR-CSMCBI8svYmJ3FAhFzn-RFUu50x61Hs2XQ9CVPm5EPQj6EYxZFfAYJ0pO6KGhcB8giPq02hmVxVg4aMP61Z7glUNrVyurmqCqXeeNCf9h-cpzPY-73NlI5v51BM5wv_AtVw6l5mM_gDWeSL5w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=4-%28pyrazol-3-ylamino%29+pyrimidine+derivatives+for+use+in+the+treatment+of+cancer&rft.inventor=NOWAK+THORSTEN%2CTHOMAS+ANDREW+P&rft.date=2007-01-10&rft.externalDBID=A&rft.externalDocID=CN1894243A